Sequenom Settles Shareholder Lawsuit for $14M

The settlement, which will be funded by insurance proceeds, relates to a lawsuit filed in November by Sequenom's shareholders alleging mishandling of data surrounding the company's SEQureDx test.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.